Private equity shop Essex Woodland yesterday said it raised $745 million for its over-subscribed second EW Healthcare Partners fund. The raise is nearly $100 million more than EW’s $650 million goal and tops its first fund b y some $200 million, the New York City-based firm said. The PE investor said it looks for fast-growing, […]
Ajax Health takes second fund to $100m
Ajax Health, the company formed in 2017 by a pair of private equity giants to manage their medical device investments, said yesterday that it added another $15 million to its second fund, taking the total to $100 million. In April the Menlo Park, Calif.-based VC shop said it raised $85 million in a round led […]
Bain raises $900m for new life science fund
Bain Capital reportedly raised $900 million for its second life sciences fund and said it would pony up 20% of its own capital for the fund, aiming to back private companies on the cusp of going public and late-stage pharma concerns in need of commercial infrastructure. The fund plans to deploy investments of $20 million […]
Report: GE is shopping its ventures arm
General Electric (NYSE:GE) is reportedly shopping its venture capital portfolio as it looks to rein in its debts in a multi-year turnaround. GE Ventures, founded in 2013, backs more than 100 start-ups across the healthcare, tech and energy sectors. It’s been seeking suitors for several months among other venture shops and limited partner groups that back […]
Report: Drug delivery investments down in Q3
Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report. Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the […]
Report: Medical device deal volume, spend down during Q3
Investors spent less money on fewer deals in the medical device sector during the third quarter and so far this year, bucking the overall growth trend for venture capital-backed firms, according to a new report. Venture capital investment fell -19.7% to $772.7 million during the three months ended Sept. 30, with deal volume down -20.3% […]
Venture fund Foresite Capital raises largest-ever $668m fund
Life sciences venture firm Foresite Capital said today that it raised a record $668 million for its fourth fund, bringing its assets-under-management tally to $2 billion. San Francisco-based Foresite was founded in 2011 by former Theravance co-founder & CEO Dr. Jim Tananbaum. Investors in its fourth fund include “a significant representation of existing investors, including […]
Orbimed founder Isaly resigns on harassment accusations
OrbiMed founder and managing partner Sam Isaly made it official last week when he relinquished control of the private equity fund in the wake of sexual harassment allegations lodged by several former employees. Six former employees accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and […]
Ex-Siemens Healthcare VC sues for retaliatory firing
A former venture capitalist with the healthcare operation at Siemens (NYSE:SI) sued the company last year, alleging that he was fired in retaliation for blowing the whistle on an alleged extortion attempt. Andrew Jay’s 14-year tenure in the German industrial conglomerate’s Boston venture shop ended in November 2017, when he declined to accept a demotion he […]
OrbiMed founder Isaly out after harassment allegations
OrbiMed founder and managing partner Sam Isaly yesterday stepped down in the wake of sexual harassment allegations lodged by several former employees of the healthcare hedge fund. In a statement released last night, New York City-based OrbiMed said Isaly is leaving “pursuant to years-long succession planning discussions” and did not address the accusations from six women, first […]
Report: Investors review hedge fund involvement in wake of harassment allegations against Orbimed founder Isaly
Institutional investors with positions in OrbiMed are reportedly reviewing their involvement with the healthcare hedge fund after sexual harassment allegations surfaced against founder and managing partner Sam Isaly. Six former employees of biotech hedge fund accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and harassing women with […]
- 1
- 2
- 3
- …
- 32
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube